Literature DB >> 12021159

Perspective: proteomics--see "spots" run.

John J Kopchick1, Edward O List, Douglas T Kohn, Gregory M O Keidan, Linghua Qiu, Shigeru Okada.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 12021159     DOI： 10.1210/endo.143.6.8882

Source DB:  PubMed          Journal:  Endocrinology        ISSN： 0013-7227            Impact factor:   4.736


× No keyword cloud information.
  6 in total

1.  Plasma Protein Biomarkers Correlated with the Development of Diet-Induced Type 2 Diabetes in Mice.

Authors:  Shigeru Okada; Edward O List; Sudha Sankaran; John J Kopchick
Journal:  Clin Proteomics       Date:  2010-06-01       Impact factor: 3.988

Review 2.  Mouse models of growth hormone action and aging: a proteomic perspective.

Authors:  Juan Ding; Lucila Sackmann-Sala; John J Kopchick
Journal:  Proteomics       Date:  2012-11-26       Impact factor: 3.984

3.  Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects.

Authors:  Lucila Sackmann-Sala; Juan Ding; Lawrence A Frohman; John J Kopchick
Journal:  Growth Horm IGF Res       Date:  2009-04-21       Impact factor: 2.372

Review 4.  Perspective: proteomic approach to detect biomarkers of human growth hormone.

Authors:  Juan Ding; Edward O List; Shigeru Okada; John J Kopchick
Journal:  Growth Horm IGF Res       Date:  2009-06-04       Impact factor: 2.372

Review 5.  A proteomic approach to obesity and type 2 diabetes.

Authors:  Elena López-Villar; Gabriel Á Martos-Moreno; Julie A Chowen; Shigeru Okada; John J Kopchick; Jesús Argente
Journal:  J Cell Mol Med       Date:  2015-05-09       Impact factor: 5.310

Review 6.  The impact of growth hormone on proteomic profiles: a review of mouse and adult human studies.

Authors:  Silvana Duran-Ortiz; Alison L Brittain; John J Kopchick
Journal:  Clin Proteomics       Date:  2017-06-29       Impact factor: 3.988
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.